Quantitative Analysis and Comparison Study of [F-18]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [Ga-68]Ga-NOTA-PRGD2 Using a Reference Tissue Model | |
Guo, Ning ; Lang, Lixin ; Li, Weihua ; Kiesewetter, Dale O. ; Gao, Haokao ; Niu, Gang ; Xie, Qingguo ; Chen, Xiaoyuan ; Chen XY(陈晓元) | |
2012-05-18 | |
关键词 | INTEGRIN ALPHA(V)BETA(3) EXPRESSION CYCLIC RGD PEPTIDES GRAPHICAL ANALYSIS CANCER-PATIENTS DYNAMIC PET TRACER ANGIOGENESIS TUMORS MICE STRATEGIES |
英文摘要 | With favorable pharmacokinetics and binding affinity for alpha(v)beta(3) integrin, F-18-labeled dimeric cyclic RGD peptide ([F-18]FPPRGD2) has been intensively used as a PET imaging probe for lesion detection and therapy response monitoring. A recently introduced kit formulation method, which uses an F-18-fluoride-aluminum complex labeled RGD tracer ([F-18]AlF-NOTA-PRGD2), provides a strategy for simplifying the labeling procedure to facilitate clinical translation. Meanwhile, an easy-to-prepare Ga-68-labeled NOTA-PRGD2 has also been reported to have promising properties for imaging integrin alpha(v)beta(3). The purpose of this study is to quantitatively compare the pharmacokinetic parameters of [F-18]FPPRGD2, [F-18]AlF-NOTA-PRGD2, and [Ga-68]Ga-NOTA-PRGD2. U87MG tumor-bearing mice underwent 60-min dynamic PET scans following the injection of three tracers. Kinetic parameters were calculated using Logan graphical analysis with reference tissue. Parametric maps were generated using voxel-level modeling. All three compounds showed high binding potential (Bp(ND) = k(3)/k(4)) in tumor voxels. [F-18]AlF-NOTA-PRGD2 showed comparable Bp(ND) value (3.75 +/- 0.65) with those of [F-18]FPPRGD2 (3.39 +/- 0.84) and [Ga-68]Ga-NOTA-PRGD2 (3.09 +/- 0.21) (p > 0.05). Little difference was found in volume of distribution (V-T) among these three RGD tracers in tumor, liver and muscle. Parametric maps showed similar kinetic parameters for all three tracers. We also demonstrated that the impact of non-specific binding could be eliminated in the kinetic analysis. Consequently, kinetic parameter estimation showed more comparable results among groups than static image analysis. In conclusion, [F-18]AlF-NOTA-PRGD2 and [Ga-68]Ga-NOTA-PRGD2 have comparable pharmacokinetics and quantitative parameters compared to those of [F-18]FPPRGD2. Despite the apparent difference in tumor uptake (%ID/g determined from static images) and clearance pattern, the actual specific binding component extrapolated from kinetic modeling appears to be comparable for all three dimeric RGD tracers.; Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; International Cooperative Program of the National Science Foundation of China (NSFC) [81028009]; NSFC [60972099, 61027006]; China Scholarship Council |
语种 | 英语 |
出版者 | PUBLIC LIBRARY SCIENCE |
内容类型 | 期刊论文 |
源URL | [http://dx.doi.org/10.1371/journal.pone.0037506] ![]() |
专题 | 物理技术-已发表论文 |
推荐引用方式 GB/T 7714 | Guo, Ning,Lang, Lixin,Li, Weihua,et al. Quantitative Analysis and Comparison Study of [F-18]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [Ga-68]Ga-NOTA-PRGD2 Using a Reference Tissue Model[J],2012. |
APA | Guo, Ning.,Lang, Lixin.,Li, Weihua.,Kiesewetter, Dale O..,Gao, Haokao.,...&陈晓元.(2012).Quantitative Analysis and Comparison Study of [F-18]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [Ga-68]Ga-NOTA-PRGD2 Using a Reference Tissue Model.. |
MLA | Guo, Ning,et al."Quantitative Analysis and Comparison Study of [F-18]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [Ga-68]Ga-NOTA-PRGD2 Using a Reference Tissue Model".(2012). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论